XON buys out Merck KGaA’s stake in CAR-T program for $150M in XON stock: https://www.prnewswire.com/news-releases/intrexon-and-merck-kgaa-darmstadt-germany-announce-agreement-realizing-precigens-vision-for-full-developmental-autonomy-of-its-car-t-program-300769521.html The CAR-T collaboration was formed in 2015 (#msg-112230886).